Related Experiment Video
Updated: Jun 17, 2026

07:46
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
5.3K
Fluidic Multivalent Membrane Nanointerface Enables Synergetic Enrichment of Circulating Tumor Cells with High
Lingling Wu1, Hongming Ding2, Xin Qu3
1Institute of Molecular Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, P. R. China.
Journal of the American Chemical Society
|February 13, 2020
Summary
Researchers developed a biomimetic nanointerface using aptamer-functionalized membrane nanovesicles on a microfluidic chip for efficient circulating tumor cell (CTC) isolation. This fluidic system significantly enhances capture efficiency and maintains CTC viability for clinical applications.
Area of Science:
- Biomaterials Science
- Biomedical Engineering
- Nanotechnology
Background:
- Cell membranes exhibit dynamic fluidity enabling multivalent interactions for biological processes.
- Current methods for isolating circulating tumor cells (CTCs) face challenges in efficiency and maintaining cell viability.
Purpose of the Study:
- To engineer a fluidic multivalent nanointerface for high-performance isolation of CTCs.
- To leverage biomimetic principles for enhanced affinity and capture efficiency in a microfluidic device.
Main Methods:
- Decorating a microfluidic chip with aptamer-functionalized leukocyte membrane nanovesicles to create a biomimetic nanointerface.
- Utilizing the fluidic nature of the interface for active recruitment and binding of CTCs.
- Comparing the performance of the multivalent nanointerface with a monovalent aptamer-functionalized chip in blood samples.
Main Results:
- Achieved a 4-order of magnitude enhancement in binding affinity.
- Demonstrated a 7-fold higher capture efficiency for CTCs compared to monovalent systems.
- Minimized background blood cell adsorption and maintained high CTC viability (97.6%).
- Successfully detected CTCs in all tested cancer patient samples (17/17).
Conclusions:
- The fluidity-enhanced multivalent binding strategy shows high potential for clinical applications in CTC detection.
- The bioengineered interface offers a novel biomimetic platform for biomedical applications by mimicking natural cell-cell interactions.
- This approach advances the design of innovative platforms using natural biomaterials and cell-cell interaction principles.

